Research Correspondence

DOI: 10.4244/EIJ-D-25-00255

Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves

Giuseppe Tarantini1, MD, PhD; Won-Keun Kim2,3,4, MD; Gerrit Kaleschke5, MD, PhD; Andreas Holzamer6, MD, PhD; Norman Mangner7, MD, PhD; Radoslaw Parma8, MD; Francesco Cardaioli1, MD; Luca Nai Fovino1, MD, PhD

Abstract

Editorial note: On 28 May 2025, the manufacturer announced the global discontinuation of sales of its ACURATE neo2 and ACURATE Prime aortic valve systems. The following correspondence, submitted and accepted prior to the market withdrawal, discusses clinical experience with this device. Though no longer relevant for current practice, the Editorial Board believes it is important to document these findings in the interest of transparency and completeness of the scientific record. Accordingly, we are publishing this work as a Research Correspondence, with acknowledgement of the device’s discontinued status.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 18
Sep 15, 2025
Volume 21 Number 18
View full issue


Key metrics

Suggested by Cory

Translational research

10.4244/EIJ-D-22-00769 May 12, 2023
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure
Akodad M et al
free

Research correspondence

10.4244/EIJ-D-22-00740 Apr 24, 2023
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis
Vanhaverbeke M et al
free

Editorial

10.4244/EIJ-E-23-00012 May 12, 2023
ACURATE neo2: jack of all trades or master of none?
Sinning J
free

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
free

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G et al

Editorial

10.4244/EIJ-E-23-00058 Jan 1, 2024
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial
Windecker S and Tomii D
free
Trending articles
96.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
66.55

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved